APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rotavirus Vaccine Industry Growth and Trends Forecast to 2032

19 December 202575 pages

Choose your research edition.

Industry ResearchRotavirus Vaccine Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Rotavirus Vaccine Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rotavirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rotavirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rotavirus Vaccine include GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rotavirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rotavirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rotavirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rotavirus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rotavirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rotavirus Vaccine Market by Company

GlaxoSmithKline Biologicals

Lanzhou Institute of Biological Products

Merck

Rotavirus Vaccine Segment by Type

RV3

RV5

Rotavirus Vaccine Segment by Application

Government Institution

Private Sector

Other

Rotavirus Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of RV3 Table 2. Major Company of RV5 Table 3. Global Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Rotavirus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rotavirus Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Rotavirus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rotavirus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rotavirus Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Rotavirus Vaccine Industry Trends Table 25. Rotavirus Vaccine Industry Drivers Table 26. Rotavirus Vaccine Industry Opportunities and Challenges Table 27. Rotavirus Vaccine Industry Restraints Table 28. Global Rotavirus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rotavirus Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Rotavirus Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Rotavirus Vaccine Sales Share by Company (2021-2026) Table 32. Global Rotavirus Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rotavirus Vaccine Major Company Production Sites and Headquarters Table 35. Global Rotavirus Vaccine Company, Product Type & Application Table 36. Global Rotavirus Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rotavirus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Rotavirus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rotavirus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rotavirus Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Rotavirus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rotavirus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rotavirus Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Rotavirus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rotavirus Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Rotavirus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rotavirus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rotavirus Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. GlaxoSmithKline Biologicals Company Information Table 72. GlaxoSmithKline Biologicals Business Overview Table 73. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio Table 75. GlaxoSmithKline Biologicals Recent Development Table 76. Lanzhou Institute of Biological Products Company Information Table 77. Lanzhou Institute of Biological Products Business Overview Table 78. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio Table 80. Lanzhou Institute of Biological Products Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Rotavirus Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. North America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 88. North America Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 89. North America Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 91. North America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Rotavirus Vaccine Market Share by Country (2021-2026) Table 94. North America Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 96. Europe Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 98. Europe Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 99. Europe Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Rotavirus Vaccine Market Share by Country (2021-2026) Table 104. Europe Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Rotavirus Vaccine Market Share by Country (2021-2026) Table 114. Asia-Pacific Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 116. Latin America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 118. Latin America Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 119. Latin America Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Rotavirus Vaccine Market Share by Country (2021-2026) Table 124. Latin America Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Rotavirus Vaccine Market Share by Country (2021-2026) Table 134. Middle East and Africa Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Rotavirus Vaccine Distributors List Table 139. Rotavirus Vaccine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Rotavirus Vaccine Image Figure 2. Global Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. RV3 Image Figure 6. Global RV3 Sales YoY Growth (2021-2032) & (K Units) Figure 7. RV5 Image Figure 8. Global RV5 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Rotavirus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rotavirus Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Institution Image Figure 24. Global Government Institution Sales YoY Growth (2021-2032) & (K Units) Figure 25. Private Sector Image Figure 26. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Rotavirus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rotavirus Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rotavirus Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rotavirus Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • RV3
  • RV5
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GlaxoSmithKline Biologicals
  • Lanzhou Institute of Biological Products
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rotavirus Vaccine Market by Type
  6. 1.3.1 RV3
  7. 1.3.2 RV5
  8. 1.4 Global Rotavirus Vaccine Market Size by Type
  9. 1.4.1 Global Rotavirus Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rotavirus Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rotavirus Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rotavirus Vaccine Industry Trends
  2. 2.2 Rotavirus Vaccine Industry Drivers
  3. 2.3 Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Rotavirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rotavirus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Rotavirus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Rotavirus Vaccine Price (2021-2026)
  4. 3.4 Global Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rotavirus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Rotavirus Vaccine Company, Product Type & Application
  7. 3.7 Global Rotavirus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Rotavirus Vaccine Regional Status and Outlook
  1. 4.1 Global Rotavirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rotavirus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Rotavirus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rotavirus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rotavirus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Rotavirus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rotavirus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rotavirus Vaccine by Application
  1. 5.1 Rotavirus Vaccine Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Rotavirus Vaccine Market Size by Application
  6. 5.2.1 Global Rotavirus Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rotavirus Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rotavirus Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline Biologicals
  2. 6.1.1 GlaxoSmithKline Biologicals Company Information
  3. 6.1.2 GlaxoSmithKline Biologicals Business Overview
  4. 6.1.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio
  6. 6.1.5 GlaxoSmithKline Biologicals Recent Developments
  7. 6.2 Lanzhou Institute of Biological Products
  8. 6.2.1 Lanzhou Institute of Biological Products Company Information
  9. 6.2.2 Lanzhou Institute of Biological Products Business Overview
  10. 6.2.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio
  12. 6.2.5 Lanzhou Institute of Biological Products Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Rotavirus Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Rotavirus Vaccine Sales by Country
  2. 7.1.1 North America Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rotavirus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rotavirus Vaccine Market Size by Country
  6. 7.2.1 North America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rotavirus Vaccine Sales by Country
  2. 8.1.1 Europe Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rotavirus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rotavirus Vaccine Market Size by Country
  6. 8.2.1 Europe Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rotavirus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rotavirus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rotavirus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rotavirus Vaccine Sales by Country
  2. 10.1.1 South America Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rotavirus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rotavirus Vaccine Market Size by Country
  6. 10.2.1 South America Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rotavirus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rotavirus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rotavirus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rotavirus Vaccine Value Chain Analysis
  2. 12.1.1 Rotavirus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rotavirus Vaccine Production Mode & Process
  7. 12.2 Rotavirus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rotavirus Vaccine Distributors
  10. 12.2.3 Rotavirus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst